Navigation Links
Biodegradable microspheres deliver time release vaccines, stimulate different immune response

ys Wilson-Welder.

The implications of these findings are two-fold, says Wilson-Welder. First, they have shown that polyanhydride microspheres can be used to deliver time-released vaccines. This could lead to the development of single-dose vaccines for diseases that currently require booster innoculations to be most effective, such as tetanus, whooping cough and chicken pox.

"The slow release mechanism of the polymers means that vaccines that currently require multiple doses might need only need a single dose in the future," says Wilson-Welder.

Secondly, the finding that vaccine adjuvants can elicit a CMI provides hope for vaccines against intracellular diseases that we currently don't have effective vaccines for, like malaria, tuberculosis and even AIDS.

"If we understand how an adjuvant activates the dendritic cells, we can start tailoring our vaccines to induce a better cellular response. If we can tailor the immune response, it holds greater promise for vaccines that we do not currently have," says Wilson-Welder.


'"/>

Source:American Society for Microbiology


Page: 1 2

Related biology news :

1. Biodegradable napkin -- featuring sensitive nanofibers -- may quickly detect biohazards
2. New methods of gene delivery using lasers
3. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
4. Self-assembled DNA buckyballs for drug delivery
5. New research could help us deliver genes for new bone formation
6. Cookbook recipes would cure disease with nontoxic DNA delivery systems
7. Discarded placentas deliver researchers promising cells similar to embryonic stem cells
8. Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies
9. Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates
10. Cellular scale drug delivery from the inside out
11. Wrinkled membranes create novel drug-delivery system
Post Your Comments:
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
(Date:6/26/2015)... 2015 ATL Technology, LLC, a top provider of ... single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Costa Rica ). This acquisition will incorporate ... with ATL Technology,s existing facility in Costa Rica ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
... and dairy products analysed in various restaurants exceed the ... to a study carried out by researchers from the ... milk in jugs and suggest that these foodstuffs need ... dairy products we analysed, 35% of the samples exceeded ...
... the Journal of Clinical Endocrinology & Metabolism , shows ... density and reduced bone size in their grandsons. "This ... mass has been demonstrated across two generations," says associate professor ... Academy. "This new risk factor may be significant for the ...
... In a major step toward commercialization of a promising ... exclusively licensed patents on inventions based on the Nell-1 ... out of the Department of Energy laboratory. The ... Nell-1 gene,s cell-signaling pathway that controls tissue growth and ...
Cached Biology News:Study recommends better handling of milk in restaurants 2Grandpa's broken hip may mean weaker bones for his grandsons 2UT-Battelle licenses tissue regeneration technologies to NellOne Therapeutics, Inc. 2
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... , July 1, 2015 InferMed ... technology will ... evidence-based clinical s olutions suite   ... and medical information products and services, announced today the acquisition ... decision support (CDS) technology company. InferMed,s Arezzo technology ...
(Date:6/30/2015)... Japan , July 1, 2015 R-Japan Co.,Ltd. ... on the Safety of Regenerative Medicine from the Ministry of ... on June 29, 2015. The fact that ... processing facility through the auditing from Pharmaceuticals and Medical Devices ... the application, allows it to provide stem cell manufacturing service ...
(Date:6/30/2015)... Kjell Lindgren , who is making final preparations for ... International Space Station , will be available for live ... 7. Lindgren will participate from the Gagarin Cosmonaut ... The interviews will be preceded at 7:30 a.m. by a ... To schedule an interview, media must contact Stephanie Stoll ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2
... Additional "FOR" Votes Required for Integra Merger, IRVINE, ... ("IsoTis"), an orthobiologics company, today reported that,less than 100,000 ... by Integra LifeSciences Holdings Corporation (NASDAQ: IART ),("Integra") ... as of August,6, 2007. Today,s special meeting of ...
... 26 PURE Bioscience (OTC,Bulletin Board: PURE), creators ... in a revolutionary new hard surface,disinfectant which kills ... the Company will present at the Biocom Investor ... Diego Marriott Del Mar. Michael L.,Krall, CEO, will ...
... Oct. 26 Pharmasset, Inc.,(Nasdaq: VRUS ) management will be ... Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference being ... York Palace Hotel in New York City. ... Officer, will provide an overview of the company on Tuesday, ...
Cached Biology Technology:IsoTis Reports Status of Merger Vote 2IsoTis Reports Status of Merger Vote 3IsoTis Reports Status of Merger Vote 4PURE Bioscience to Present at Biocom Investors Conference 2PURE Bioscience to Present at Biocom Investors Conference 3PURE Bioscience to Present at Biocom Investors Conference 4Pharmasset to Present at Three Investor Conferences in November 2007 2
... FAST RED Chromogen System consists ... substrate buffer. FAST RED reacts ... phosphatase to produce red staining ... The FAST RED ...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Full length YebU (Escherichia coli)...
Human Cell Line Slides...
Biology Products: